The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Experimental NIDDM: Development of a New Model in Adult Rats Administered Streptozotocin and Nicotinamide
Abstract
We took advantage of the partial protection exerted by suitable dosages of nicotinamide against the β-cytotoxic effect of streptozotocin (STZ) to create a new experimental diabetic syndrome in adult rats that appears closer to NIDDM than other available animal models with regard to insulin responsiveness to glucose and sulfonylureas. Among the various dosages of nicotinamide tested in 3-month-old Wistar rats (100–350 mg/kg body wt), the dosage of 230 mg/kg, given intraperitoneally 15 min before STZ administration (65 mg/kg i.v.) yielded a maximum of animals with moderate and stable nonfasting hyperglycemia (155 ± 3 vs. 121 ± 3 mg/dl in controls; P < 0.05) and 40% preservation of pancreatic insulin stores. We also evaluated β-cell function both in vitro and in vivo 4–9 weeks after inducing diabetes. In the isolated perfused pancreas, insulin response to glucose elevation (5–11 mmol/l) was clearly present, although significantly reduced with respect to controls (P < 0.01). Moreover, the insulin response to tolbutamide (0.19 mmol/l) was similar to that observed in normal pancreases. Perfused pancreases from diabetic animals also exhibited a striking hypersensitivity to arginine infusion (7 mmol/l). In rats administered STZ plus nicotinamide, intravenous glucose tolerance tests revealed clear abnormalities in glucose tolerance and insulin responsiveness, which were interestingly reversed by tolbutamide administration (40 mg/kg i.v.). In conclusion, this novel NIDDM syndrome with reduced pancreatic insulin stores, which is similar to human NIDDM in that it has a significant response to glucose (although abnormal in kinetics) and preserved sensitivity to tolbutamide, may provide a particularly advantageous tool for pharmacological investigations of new insulinotropic agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yamamoto, H., Uchigata, Y., & Okamoto, H. (1981) · Nature · doi:10.1038/294284a0 · Cited by 526
Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release.
Bonner-Weir, S., Trent, D. F., & Weir, G. C. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110910 · Cited by 467
THE PLASMA INSULIN RESPONSE TO GLUCOSE INFUSION IN HEALTHY SUBJECTS AND IN DIABETES MELLITUS
Cerasi, E., & Luft, R. (1967) · Acta Endocrinologica · doi:10.1530/acta.0.0550278 · Cited by 371
Quantitation of Endocrine Cell Content in the Pancreas of Nondiabetic and Diabetic Humans
Stefan, Y., Orci, L., Malaisse-Lagae, F., Perrelet, A., Patel, Y., & Unger, R. H. (1982) · Diabetes · doi:10.2337/diab.31.8.694 · Cited by 272
β-Cell Insensitivity to Glucose in the GK Rat, a Spontaneous Nonobese Model for Type II Diabetes
Portha, B., Serradas, P., Bailbé, D., Suzuki, K.-I., Goto, Y., & Giroix, M.-H. (1991) · Diabetes · doi:10.2337/diab.40.4.486 · Cited by 262
Islet Secretion in a New Experimental Model for Non-insulin-dependent Diabetes
Weir, G. C., Clore, E. T., Zmachinski, C. J., & Bonner-Weir, S. (1981) · Diabetes · doi:10.2337/diab.30.7.590 · Cited by 248
�stenson, C. G., Khan, A., Abdel-Halim, S. M., Guenifi, A., Suzuki, K., Goto, Y., & Efendic, S. (1993) · Diabetologia · doi:10.1007/bf00399086 · Cited by 247
The rat models of non-insulin dependent diabetes induced by neonatal streptozotocin.
Portha, B., Blondel, O., Serradas, P., McEvoy, R. D., Giroix, M.-H., Kergoat, M., & Bailbé, D. (1989) · PubMed · Cited by 172
Okamoto, H. (1981) · Molecular and Cellular Biochemistry · doi:10.1007/bf02355886 · Cited by 141
Giroix, M.-H., Portha, B., Kergoat, M., Bailbé, D., & Picon, L. (1983) · Diabetes · doi:10.2337/diab.32.5.445 · Cited by 138
Giroix, M.-H., Vesco, L., & Portha, B. (1993) · Endocrinology · doi:10.1210/endo.132.2.8425496 · Cited by 83
Movassat, J., Saulnier, C., & Portha, B. (1995) · PubMed · Cited by 59
Pyridine Nucleotide Depletion in Pancreatic Islets Associated with Streptozotocin-induced Diabetes
Ho, C.-K., & Hashim, S. A. (1972) · Diabetes · doi:10.2337/diab.21.7.789 · Cited by 57
Schweisheimer, W. (1964) · PubMed · Cited by 51
Grill, V., Westberg, M., & Östenson, C. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113119 · Cited by 46
Long-term changes in the diabetic state induced by different doses of streptozotocin in rats.
Tancrède, G., Rousseau-Migneron, S., & Nadeau, A. (1983) · PubMed · Cited by 43
Cited by
Srinivasan, K., Viswanad, B., Asrat, L., Kaul, C. L., & Ramarao, P. (2005) · Pharmacological Research · doi:10.1016/j.phrs.2005.05.004 · Cited by 1,874
Streptozotocin‐Induced Diabetic Models in Mice and Rats
Furman, B. L. (2015) · Current Protocols in Pharmacology · doi:10.1002/0471141755.ph0547s70 · Cited by 1,232
Streptozotocin‐Induced Diabetic Models in Mice and Rats
Furman, B. L. (2021) · Current Protocols · doi:10.1002/cpz1.78 · Cited by 874
Role of animal models in biomedical research: a review
Mukherjee, P., Roy, S., Ghosh, D., & Nandi, S. K. (2022) · Laboratory Animal Research · doi:10.1186/s42826-022-00128-1 · Cited by 502
Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion
Ling, C., Del Guerra, S., Lupi, R., Rönn, T., Granhall, C., Luthman, H., Masiello, P., Marchetti, P., Groop, L., & Del Prato, S. (2008) · Diabetologia · doi:10.1007/s00125-007-0916-5 · Cited by 495
“a Male Wistar rats (2–3 months old) were treated with STZ–NA (n=5) or vehicles (control; n=5) [10, 11] and PPARGC1A mRNA expression together with the internal standard cyclophilin A was analysed in pancreatic islets isolated from STZ–NA-treated animals showing a stable hyperglycaemia (8.”
MethodSelf-citation
Metadata
- Authors
- Masiello, P., Broca, C., Gross, R., Roye, M., Manteghetti, M., Hillaire-Buys, D., Novelli, M., & Ribes, G.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1998-02-01
- Volume
- 47
- Issue
- 2
- Pages
- 224-229
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2138013119
- Cited by
- 781
- References
- 16
- FWCI
- 1.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.